Report: Lessons Learned from the Current Crop of Biotech Startups TOC

Executive Summary
- Strategic Considerations
- Stakeholder Implications
Overview
State of the Market
Molecular Insight Pharmaceuticals: Focus on Core Technology
NeurogesX: Consider the Peripherals
NovaBay Pharmaceuticals: Target Unmet Need
Optimer Pharmaceuticals: Offer a Unique Perspective
Orexigen Therapeutics: Build Synergies
Rosetta Genomics: Form Timely Partnerships
Advice to Young Companies
- Choosing a Strategy: The IPO Road Show
- Consider Investor Relations
- Solid Upper Management
Outlook

Nanotechnology: From Academic Innovations to Cutting-Edge Companies
- Nanotechnology in Medicine
- Nanotechnology for Biotech and Pharma
- BIND and Selecta
The Trials and Tribulations of Going Public
- One Piece at a Time
- Parting Advice for CEOs of Tomorrow' s Public Companies
How to Get Your Research Out of the Laboratory:
A Primer for the Academic Entrepreneur
- Find a Mentor (or Several)
- Document Your Research
- Disclose Early and Often
- “I Don' t Want to Make Money from My Research. I' m a Scientist.”
- Work with Your Technology Office on the Patent Filing
- Know When Your Technology Is Ready to Be Licensed
- Become Very Familiar with Your Institution' s Conflict of Interest Polices
- Should I License the Technology to an Existing Company or Start a New Company?
  - Licensing to an Existing Company
  - Starting a Company Around Your Technology
- What Happens to the Income Generated by the License?
- Getting Started on a Startup
  - Make Sure Your Patents Are in Place
  - It' s All About the Product!
  - Will the Company Be Virtual or Real?
  - Will You Work at the Company or Remain in Your Academic Position?
  - Form a Team
  - Develop a Plan
  - How Much Money Do I Need?
  - What Kind of Investors Will You Approach?
  - Will You Take a Position on the Board of Directors?
  - What Are the Most Common Mistakes to Avoid?
  - Why Bother?

Lessons Learned from the Current Crop of Biotech Startups